Weil is advising Churchill Capital Corp VII (Churchill VII), a special purpose acquisition company, in its definitive agreement for a business combination with CorpAcq Holdings Limited (CorpAcq), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses. The transaction values CorpAcq at a pro forma enterprise value of approximately $1.58 billion.
Churchill Capital invests in, executes value-enhancement strategies for and provides other support for high-quality, entrepreneurial businesses in the public markets. Upon closing of the transaction, the combined company will operate as CorpAcq and intends to list on the New York Stock Exchange.
Michael Klein, Chairman and CEO of Churchill VII, said, "When we launched Churchill VII, we wanted to identify a profitable, cash flow generating partner with strong management, a highly differentiated business model and clear growth opportunities. We believe CorpAcq fits all our criteria and more with its proven acquisition and operating strategy, established positioning in the UK SME space, track record of topline growth and profitability and talented management team."
The Weil team was led by Mergers & Acquisitions partner Michael J. Aiello and includes Mergers & Acquisitions partners Matthew Gilroy and Amanda Fenster.